# US 2026/0224130 A1 · Systems and methods for detecting and treating neurophysiological impairment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0224130 A1
- Document ID: US20260224130A1
- Status: Published application
- Kind: A1
- Application number: 19/566,749
- Filed: 2026-03-13
- Published: 2026-08-06
- Earliest claimed: 2021-02-14
- Assignees: Neursantys, Inc.
- Applicants: Neursantys, Inc.
- Inventors: John D. RALSTON; Ryan Michael PETERS; Christopher J. BANMAN
- Web page: https://patentgrep.com/patent/US20260224130A1

## CPC

- A61B 5/1126: {using a particular sensing technique}
- A61B 5/1116: {Determining posture transitions}
- A61B 5/4023: {Evaluating sense of balance}
- A61B 5/4842: {Monitoring progression or stage of a disease}
- A61B 5/4848: {Monitoring or testing the effects of treatment, e.g. of medication}
- A61B 5/6814: {Head}
- A61B 5/7264: {Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61N 1/0456: {Specially adapted for transcutaneous electrical nerve stimulation [TENS]}
- A61N 1/36025: {for treating a mental or cerebral condition}
- A61N 1/36031: {using physiological parameters for adjustment}
- A61N 1/36046: {of the eye}
- G16H 20/30: relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
- G16H 40/63: for local operation
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 50/50: for simulation or modelling of medical disorders
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- A61B 2562/0219: Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
- A61N 1/0484: {Garment electrodes worn by the patient}
- A61N 1/0526: {Head electrodes (A61N1/0551 takes precedence)}
- A61N 1/36036: {of the outer, middle or inner ear}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A system includes a sensing assembly configured to be disposed on a mastoid of a user. The sensing assembly includes a housing, a first sensor disposed in the housing and configured to measure a first phybrata signal from the user, and a second sensor disposed in the housing and configured to measure a second phybrata signal from the user, the second phybrata signal different from the first phybrata signal. A controller is in communication with the sensing assembly. The controller is configured to: receive a first phybrata data from the sensing assembly, the first phybrata data including information obtained from the first phybrata signal and the second phybrata signal. The controller is configured to determine a phybrata parameter associated with the user based on the first phybrata data, and determine a phybrata signature associated with the user based on the phybrata parameter.

## Claims

### Claim 1

A system, comprising:
a sensing assembly configured to be disposed on a mastoid of a user, the sensing assembly including:
a housing,
a first sensor disposed in the housing and configured to measure a first phybrata signal from the user, and
a second sensor disposed in the housing and configured to measure a second phybrata signal from the user, the second phybrata signal different from the first phybrata signal; and
a controller in communication with the sensing assembly, the controller configured to:
receive a first phybrata data from the sensing assembly, the first phybrata data including information obtained from the first phybrata signal and the second phybrata signal,
determine a phybrata parameter associated with the user based on the first phybrata data, and
determine a phybrata signature associated with the user based on the phybrata parameter.

### Claim 2 (depends on 1)

The system of claim 1, wherein the first phybrata signal includes a linear acceleration measured over a period of time.

### Claim 3 (depends on 1)

The system of claim 1, wherein the second phybrata signal includes a rotational velocity measured over a period of time.

### Claim 4 (depends on 1)

The system of claim 1, wherein the phybrata parameter include spatial-domain parameters, time-domain parameters, or frequency-domain parameters, each of the spatial-domain parameters, time-domain parameters, or frequency-domain parameters including at least one of temporal acceleration plots, spatial scatter plots, eyes open (Eo) powers, eyes closed (Ec) powers, receiver operating characteristic (ROC) curves, phybrata power spectral density (PSD) plots, time-resolved phybrata power spectral density (TRPSD) plots, or sensory reweighting responses.

### Claim 5 (depends on 1)

The system of claim 1, wherein the phybrata signature includes at least one of spatial-domain phybrata features, time-domain phybrata features, or frequency-domain phybrata features.

### Claim 6 (depends on 1)

The system of claim 1, wherein the controller is further configured to:
determine a quantitative phybrata metric based on the phybrata signature, the quantitative phybrata metric configured to independently classify, quantify, and/or track a magnitude and time evolution of at least one of a balance performance, a postural stability performance, a movement performance, a physiological disruption, or a physiological impairment associated with the user.

### Claim 7 (depends on 1)

The system of claim 1, wherein the controller is further configured to:
generate synthetic phybrata data associated with the user based on the first phybrata data;
determine synthetic phybrata parameters associated with the user based on the determined phybrata parameter;
determine a synthetic phybrata signature associated with the user based on the determined phybrata signature; and
determine a synthetic quantitative phybrata metric based on the synthetic phybrata signature, the synthetic quantitative phybrata metric configured to classify, quantify, and/or track a magnitude and time evolution of at least one of a balance performance, a postural stability performance, a movement performance, a physiological disruption, or a physiological impairment associated with the user.

### Claim 8 (depends on 1)

The system of claim 1, wherein the controller is further configured to:
generate a biomechanical model of the user;
generate simulated phybrata data associated with the biomechanical model of the user based on the first phybrata data;
determine simulated phybrata parameters associated with the biomechanical model of the user based on the determined phybrata parameter;
determine a simulated phybrata signature associated with the biomechanical model of the user based on the determined phybrata signature; and
determine a simulated quantitative phybrata metric based on the simulated phybrata signature, the simulated quantitative phybrata metric configured to classify, quantify, and/or track a magnitude and time evolution of at least one of a balance performance, a postural stability performance, a movement performance, a physiological disruption, or a physiological impairment associated with the user.

### Claim 9 (depends on 8)

The system of claim 8, wherein the biomechanical model is configured to include a range of neurosensory inputs and neuromotor outputs associated with the user.

### Claim 10 (depends on 8)

The system of claim 8, wherein the controller is further configured to:
generate adjusted phybrata data based on the first phybrata data, the synthetic phybrata data, and the simulated phybrata data; and
determine an adjusted phybrata signature indicative of the adjusted phybrata data associated with the user.

### Claim 11 (depends on 10)

The system of claim 10, wherein the controller is further configured to:
receive a second phybrata data from the sensing assembly;
compare the second phybrata data with the adjusted phybrata data;
generate predictive data based on the comparison between the second phybrata data and the adjusted phybrata data, the predictive data indicative of projected physiological changes in the user; and
generate a predictive phybrata signature indicative of the predictive data.

### Claim 12 (depends on 11)

The system of claim 11, wherein the projected physiological changes include changes in at least one of a balance performance, a postural stability performance, or a movement performance of the user.

### Claim 13 (depends on 11)

The system of claim 11, wherein the projected physical changes include changes in a disease state of the user.

### Claim 14 (depends on 13)

The system of claim 13, wherein the disease state includes at least one of a concussion, a stroke, Parkinson's diseases, multiple sclerosis, elderly frailty, peripheral neuropathy, peripheral arterial disease, spinal stenosis, chronic pain, or invasive surgery.

### Claim 15 (depends on 11)

The system of claim 11, wherein the projected physical changes include changes in a response to a treatment, a medication, a therapy, or rehabilitation.

### Claim 16

A system, comprising:
a stimulation assembly, including:
a housing configured to be worn on a body of a user, and
a set of electrodes coupled to the housing, at least a portion of the set of electrodes configured to be disposed on a mastoid of the user; and
a controller in communication with the stimulation assembly, the controller configured to:
receive a phybrata signature associated with the user,
determine stimulation signal parameters based on the phybrata signature, and
selectively generate a signal based on the stimulation signal parameters, the signal configured to activate at least one pair of the set of electrodes to apply a stimulation signal to the user corresponding to the stimulation signal parameters.

### Claim 17 (depends on 16)

The system of claim 16, wherein the stimulation assembly is structed to be worn around a neck of the user.

### Claim 18 (depends on 16)

The system of claim 16, wherein the portion of the set of electrodes is a first portion, a second portion of the set of electrodes configured to be disposed on a neck of the user.

### Claim 19 (depends on 16)

The system of claim 16, wherein:
the set of electrodes include electrical vestibular stimulation (EVS) electrodes;
the phybrata signature is indicative of a at least one of a vestibular impairment, an unwanted physical motion, a head tremor, or a fall; and
the stimulation signal comprises a therapeutic EVS signal or a corrective EVS signal.

### Claim 20 (depends on 19)

The system of claim 19, wherein:
the stimulation signal is an EVS waveform; and
the controller is further configured to:
determine, based on the phybrata signature, relative timings for a postural reaction and anticipatory adjustment of the user,
calculate a predicted physiological signature associated with the user, the predicted physiological signature including at least one of a predicted magnitude, a predicted phase, and a predicted delay between motions of different segments of a body of the user, and
generate and selectively adjust parameters of the EVS waveform applied to the user based on the predicted physiological signature so as to adjust the balance performance, postural stability performance, or movement performance of the user.

### Claim 21 (depends on 20)

The system of claim 20, wherein:
the phybrata signature is indicative of a vestibular impairment in the user due to age, injury, or disease; and
the stimulation signal is configured to correct the vestibular impairment.

### Claim 22 (depends on 20)

The system of claim 20, wherein the therapeutic EVS signal is configured to improve disrupted balance performance, postural stability performance, or movement performance.

### Claim 23 (depends on 20)

The system of claim 20, wherein the corrective EVS signal is configured to induce a postural response in the user back towards a neutral position to reduce the risk of a fall.

### Claim 24 (depends on 20)

The system of claim 20, wherein the corrective EVS signal is configured to reduce a head tremor.

### Claim 25 (depends on 20)

The system of claim 20, wherein the corrective EVS signal is configured to reduce heart rate variability associated with postural orthostatic tachycardia syndrome (POTS).

### Claim 26 (depends on 16)

The system of claim 16, wherein the set of electrodes include cranial electrical stimulation (CES) electrodes.

### Claim 27 (depends on 26)

The system of claim 26, wherein:
the stimulation signal is a CES waveform; and
the controller is further configured to:
determine, based on the phybrata signature, relative timings for a postural reaction and anticipatory adjustment of the user, and
calculate a predicted neurological signature associated with the user, the predicted neurological signature including at least one of a predicted magnitude, a predicted phase, and a predicted delay between motions of different segments of a body of the user, and
generate and selectively adjust parameters of the CES waveform applied to the user based on the predicted neurological signature to adjust a neuromotor, neurosensory, neurocognitive, or neuropsychological impairment of the user.

### Claim 28 (depends on 16)

The system of claim 16, wherein the set of electrodes include electrical stimulation of the eye (ESE) electrodes.

### Claim 29 (depends on 28)

The system of claim 28, wherein:
the stimulation signal is an ESE waveform; and
the controller is further configured to:
determine, based on the phybrata signature, relative timings for a postural reaction and anticipatory adjustment of the user, and
calculate a predicted neurological signature associated with the user, the predicted neurological signature including at least one of a predicted magnitude, a predicted phase, and a predicted delay between motions of different segments of a body of the user, and
generate and selectively adjust parameters of the ESE waveform applied to the user based on the predicted neurological signature to adjust a neuromotor or neurosensory impairment of the user.

### Claim 30 (depends on 29)

The system of claim 29, wherein:
the neurosensory impairment is optical neuritis caused by one or more multiple sclerosis lesions on the optic nerve.

### Claim 31

A system, comprising:
a sensing and stimulation assembly, including:
a housing,
a first sensor disposed in the housing and configured to measure a first phybrata signal from the user,
a second sensor disposed in the housing and configured to measure a second phybrata signal from the user, the second phybrata signal being different from the first phybrata signal, and
a set of electrodes coupled to the housing, at least a portion of the set of electrodes configured to be disposed on a mastoid of the user; and
a controller communicatively coupled to the sensing and stimulation assembly, the controller configured to:
receive phybrata data from the sensing assembly, the phybrata data including information obtained from the first phybrata signal and the second phybrata signal,
determine a phybrata parameter associated with the user based on the phybrata data,
determine a phybrata signature associated with the user based on the phybrata parameter,
determine stimulation signal parameters based on the phybrata signature, and
selectively generate a signal based on the stimulation signal parameters, the signal configured to activate at least one pair of the set of electrodes to apply a stimulation signal to the user corresponding to the stimulation signal parameters.
